Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Creating EEG biomarkers to predict treatment efficacy of theta-burst rTMS in major depressive disorder

EF 2015-16

Résumé
Major depressive disorder (MDD) is a highly prevalent and debilitating neurological disorder, and has been labeled as the third leading contributor to the global disease burden. Characterized by depressed mood, suicidality, and loss of pleasure in everyday activities, MDD often occurs in conjunction with other disorders including posttraumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), generalized anxiety disorder, and substance abuse. Despite the fact that around 16% of people will have MDD in their lives, nearly 15% of MDD patients will present with refractory depression, where two or more different antidepressant medications have failed. Thus, there have been calls for the creation of new treatments for MDD that are both personalized and highly effective. One such treatment is repetitive transcranial magnetic stimulation (rTMS). A form of rTMS, known as theta-burst stimulation, will be applied to the dorsomedial prefrontal cortex (dmPFC), an area of the brain involved in emotion regulation. Electroencephalography (EEG) will be used to measure distinct patterns of brain activity from each patient prior to treatment in order to develop predictive biomarkers, which would greatly improve the efficacy of rTMS by personalizing the treatment. Given that patients who respond to the treatment would be more likely to return to work and less likely to require long-term disability support, rTMS could have a positive impact on both the overall rates of refractory depression and on the significant social, economic, and health costs of the disease itself.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
349991
Name
Fettes Peter
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Creating EEG biomarkers to predict treatment efficacy of theta-burst rTMS in major depressive disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Eeg; Major Depressive Disorder; Rtms; Theta-Burst Stimulation; Translational Research
Abstract
Major depressive disorder (MDD) is a highly prevalent and debilitating neurological disorder, and has been labeled as the third leading contributor to the global disease burden. Characterized by depressed mood, suicidality, and loss of pleasure in everyday activities, MDD often occurs in conjunction with other disorders including posttraumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), generalized anxiety disorder, and substance abuse. Despite the fact that around 16% of people will have MDD in their lives, nearly 15% of MDD patients will present with refractory depression, where two or more different antidepressant medications have failed. Thus, there have been calls for the creation of new treatments for MDD that are both personalized and highly effective. One such treatment is repetitive transcranial magnetic stimulation (rTMS). A form of rTMS, known as theta-burst stimulation, will be applied to the dorsomedial prefrontal cortex (dmPFC), an area of the brain involved in emotion regulation. Electroencephalography (EEG) will be used to measure distinct patterns of brain activity from each patient prior to treatment in order to develop predictive biomarkers, which would greatly improve the efficacy of rTMS by personalizing the treatment. Given that patients who respond to the treatment would be more likely to return to work and less likely to require long-term disability support, rTMS could have a positive impact on both the overall rates of refractory depression and on the significant social, economic, and health costs of the disease itself.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fettes, Peter
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~